AMPLY Discovery is a drug and nutraceutical discovery company based in Northern Ireland. A spin-out company from Queen's University Belfast, we use machine learning and AI to discover new therapeutic molecules for hard-to-treat diseases. This includes developing new drugs to replace conventional antibiotics and help tackle AMR. Our discovery platform is designed to mine vast biological datasets in silico and validate hundreds of hits in vitro.
Current CEO of AMPLY Discovery - an AI driven animal health anti-infectives startup. Formerly postdoctoral researcher working on anti-infectives, AMR, novel antimicrobials and computational biology in the CreeveyLab at Queen's University, Belfast. A visiting researcher at Aberystwyth University. Creator of AMPLY, a machine learning driven tool that analyses bioinformatic data to discover novel bioactive peptides. Focus on animal health, microbiome, bioinformatics and AMR. Longer term background in database management, data science, project and program management and technical consultancy.